... Resonance Imaging of the brain in each case Two patients with POTS, who were followed at our clinic, developed multiplesclerosis after being diagnosed with POTS Criterion for diagnosis of POTS: The diagnosis ... cardiovascular dysautonomia in multiplesclerosis Acta Neurol Scand 1996;93:241–245 Linden D, Diehl RR, Berlit P Subclinical autonomic dis-turbances in multiplesclerosis J Neurol 1995;242:374– ... T Cardiovascular dysfunction in multiplesclerosis Acta Neurol Scand 2000;101:85–88 Linden D, Diehl RR, Berlit P Subclinical autonomic dis-turbances in multiplesclerosis J Neurol 1995;242:374–...
... fatigue on patients withmultiplesclerosis Can J Neurol Sci Feb 1994; 21(1):9–14 Minden S, Frumin M, Erb J Treatment of disorders of mood and affect in multiplesclerosisMultiplesclerosis therapeutics ... clinical course of multiple sclerosis: Results of an international survey National multiplesclerosis society (USA) advisory committee on clinical trials of new agents in multiplesclerosis Neurology ... Zikan V Bone health in patients withmultiplesclerosis Journal of O steoporosis 2011:596294 Hussein WI, Reddy SS Prevalence of diabetes in patients withmultiplesclerosis Diabetes Care Aug 2006;29(8):1984–5...
... life of persons withmultiple sclerosis: the possible warning signs Mult Scler 2007, 13(8):1038-1045 MultipleSclerosis Council for Clinical Practice Guidelines: Fatigue and multiple sclerosis: evidence-based ... correlated with the Physical but not the General or Mental scales of the Multidimensional Fatigue Inventory [32] Figure Fatigue scores in people withmultiplesclerosis Fatigue scores in people withmultiple ... longitudinal study of persons withmultiplesclerosis Arch Phys Med Rehabil 2006, 87(7):935-943 Iriarte J, Subira ML, Castro P: Modalities of fatigue in multiple sclerosis: correlation with clinical and...
... withmultiplesclerosis Tissue Antigens 1998, 51:301-304 Alvarez-Cermeno JC, Villar LM, Nocito M, Tootello A, GonzalezPorque P: Intrathecal synthesis of soluble class I antigens in multiplesclerosis ... line) in multiplesclerosis patients Demonstration of the distribution curves for soluble HLA-II levels in the cerebrospinal fluid (unbroken line) and saliva (dotted line) in multiplesclerosis ... HLA class II levels in the saliva of multiplesclerosis patients versus controls Figure Demonstration of soluble HLA class II levels in the saliva of multiplesclerosis patients versus controls...
... life of persons withmultiple sclerosis: the possible warning signs Mult Scler 2007, 13(8):1038-1045 MultipleSclerosis Council for Clinical Practice Guidelines: Fatigue and multiple sclerosis: evidence-based ... correlated with the Physical but not the General or Mental scales of the Multidimensional Fatigue Inventory [32] Figure Fatigue scores in people withmultiplesclerosis Fatigue scores in people withmultiple ... longitudinal study of persons withmultiplesclerosis Arch Phys Med Rehabil 2006, 87(7):935-943 Iriarte J, Subira ML, Castro P: Modalities of fatigue in multiple sclerosis: correlation with clinical and...
... metabolism in multiplesclerosis Arch Neurol 1992, 49:649-652 Besler HT, Comoglu S: Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients withmultiplesclerosis ... homocysteine (Hcy) and vitamin B12 in multiplesclerosis (MS) patients and controls Box and1 Box and whisker plot of plasma homocysteine (Hcy) and vitamin B12 in multiplesclerosis (MS) patients and controls ... Brattstrom L, Kagedal B: Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients withmultiplesclerosis Page of (page number not for citation purposes) Annals...
... performed in the entire patient’s cohort as well as in sub-groups of patients with or without relapse and patients with or without NAbs At each time point, a Mann-Whitney test was performed to identify ... neopterin and kyn/ trp ratio and its correlation with the clinical features in patients with RRMS treated with two different doses of IFNb-1a Treatment with IFNb-1a (both LD and HD) increased serum ... marker of disease activity in multiplesclerosis Brain 1997, 120(Pt 1):1-13 Sorensen PS: Biological markers in body fluids for activity and progression in multiplesclerosis Mult Scler 1999, 5:287-290...
... clinical course of multiple sclerosis: results of an international survey National MultipleSclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in MultipleSclerosis Neurology ... documented relapses which resolved with intravenous glucocorticoid therapy The relapses decreased in frequency during this time, after which her clinical status deteriorated, with progressive development ... upper extremities with OMS (Oxford Muscle Strength) score of 2–3 out of (Table 1) and an EDSS score of 8.0 Neurological presentation included paraplegia, bilateral central scotomata with visual-field...
... manuscript D.G was supported by MultipleSclerosis Society of Great Britain We thank Ms Jessica De Jullian for technical assistance in manuscript preparation MS: multiplesclerosis AL: acute lesion ... degeneration and progressive neurology disability in multiplesclerosis Neurotox Res 2003, 5:157-64 Lassmann H, Bruck W, Lucchinetti C: Heterogeneity of multiplesclerosis pathogenesis: implications for ... binding proteins in multiplesclerosis plaques Neuropath and App Neurobio 1999, 25:215-25 Gveric D, Herrera BM, Cuzner ML: Receptors and the Fibrinolytic Response in MultipleSclerosis Lesions...
... MMP-9, IL-12p40 and IL-23 in multiplesclerosis patients treated with interferon-beta1b Mult Scler 2010, 16:801-809 29 Minagar A, Jy W, Jimenez JJ, Alexander JS: Multiplesclerosis as a vascular disease ... MRI characteristics, and lipid profiles of patient subsets with and without statins Variable No Statins Statins p-value Females: Males (% Female) 301: 81 (78.8%) 69: 40 (63.3%) < 0.002§ 0.075‡ MS ... Acknowledgements Support from the National MultipleSclerosis Society (RG3743 and a Pediatric MS Center of Excellence Center Grant) and the Department of Defense MultipleSclerosis Program (MS090122) is...
... performed in the entire patient’s cohort as well as in sub-groups of patients with or without relapse and patients with or without NAbs At each time point, a Mann-Whitney test was performed to identify ... neopterin and kyn/ trp ratio and its correlation with the clinical features in patients with RRMS treated with two different doses of IFNb-1a Treatment with IFNb-1a (both LD and HD) increased serum ... marker of disease activity in multiplesclerosis Brain 1997, 120(Pt 1):1-13 Sorensen PS: Biological markers in body fluids for activity and progression in multiplesclerosis Mult Scler 1999, 5:287-290...
... measure for people withmultiplesclerosis Clin Rehabil 2001, 15:247-25 18 Ford HL, Gerry E, Johnson MH, Tennant A: Health status and quality of life of people withmultiplesclerosis Disabil ... Relapsing multiplesclerosis patients (FLAIR) study group: Improvement of healthrelated quality of life in relapsing remitting multiplesclerosis patients after years of treatment with intramuscular ... Quality of life for veterans withmultiplesclerosis on disease-modifying agents: Relationship to disability J Rehabil Res Dev 2006, 43:25-44 11 Ziemssen T: Multiplesclerosis beyond EDSS: depression...
... Methods 1997, 205:35-41 The MultipleSclerosis Collaborative Research Group (MSCRG): Intramuscular interferon-beta-1a for disease progression in relapsing-remitting multiplesclerosis Ann Neurol 1996, ... 44:259-263 Panitch H, Hirsch R, Schindler J, Johnson K: Treatment of multiplesclerosiswith gamma interferon: exarcebations associated with activation of the immune system Neurology 1987, 37:1097-1102 ... 18 http://www.jnrbm.com/content/3/1/4 The INFB MultipleSclerosis Study Group: Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: Clinical results of a multicenter, randomized,...
... causes and treatment of multiplesclerosis Nature 1999, 399:A40-A47 Christensen T: Association of human endogenous retroviruses withmultiplesclerosis and possible interactions with herpes viruses ... patients withmultiplesclerosis PNAS 1997, 94:7583-7588 Garson JA, Tuke PW, Giraud P, Paranhos-Baccala G, Perron H: Detection of virion-associated MSRV-RNA in serum of patients withmultiplesclerosis ... samples 23 patients with active MS (18 females and males, age 47 ± 11 years), 23 patients with stable MS (14 females and males, age 49 ± 15 years), 22 healthy controls (11 females and 11 males,...
... Pointers and Memory Addresses Physical and Virtual Memory Addressing and Indirection Functions withMultiple Outputs Arrays and Pointer Arithmetic Strings String Utility Functions Searching and ... faults, other difficult-to-identify errors • What happens if we dereference ppi now? 11 Functions withmultiple outputs • Consider the Extended Euclidean algorithm ext_euclid(a,b) function from Wednesday’s ... Pointers and Memory Addresses Physical and Virtual Memory Addressing and Indirection Functions withMultiple Outputs Arrays and Pointer Arithmetic Strings String Utility Functions Searching and...
... 1-932603-54-9 (pbk : alk paper) Multiplesclerosis Alternative treatment I Bowling, Allen C Alternative medicine and multiplesclerosis II Title [DNLM: MultipleSclerosis therapy Complementary ... providers and people with MS Additional Readings Websites www.ms-cam.org CAM website of the Rocky Mountain MultipleSclerosis Center Books Bourdette D, Yadav V, Shinto L Multiplesclerosis In: Oken ... Complementary and Alternative Medicine and MultipleSclerosis Second Edition This page intentionally left blank Complementary and Alternative Medicine and MultipleSclerosis Second Edition Allen C Bowling,...
... of translation edit rate with targeted human annotation In AMTA Valentin I Spitkovsky, Hiyan Alshawi, and Daniel Jurafsky 2011 Lateen em: Unsupervised training withmultiple objectives, applied ... different metrics Mk (h) for evaluating the quality of h Without loss of generality, we assume metric scores are bounded between and 1, with being perfect Each hypothesis h can be mapped to a ... circle (o) are pareto-optimal, while those with plus (+) are not To visualize this, take for instance the paretooptimal point (0.4,0.7) There is no other point with either (metric1 > 0.4 and metric2...
... to achieve performance competitive with, or even superior to, that of B&L’s model without knowing the true coherence score given by human judges Evaluating our multiple- rank model in this task ... generation 5.1.1 Rank Assignment In our multiple- rank model, pairwise rankings between a source document and its permutations are extended into a longer ranking withmultiple ranks We assign a rank to ... is not significant, which suggests that our multiple- rank model with unsupervised score assignment via simple cosine matching can remain competitive with the standard model, which requires human...
... deliberation over meeting times within a single monolithic discourse segment, leaving the vast majority of the dialogue with no segmentation As a result, we are left with the question of how to account ... account for shifts in focus which seem to occur within the deliberation segment as evidenced by the types of pronominal references which occur within it For example, in the dialogue presented ... structured stack is a stack which can have multiple top elements at any point Because it is possible to maintain more than one top element, it is possible to separate multiple threads in discourse by allowing...
... Managing your MultipleSclerosis Comments on Managing your MultipleSclerosis ‘The book is well written, clear and accurate – it will be a good reference book for people with MS.’ D R S ANDY ... of multiplesclerosis ) where the demyelination has occurred Thus the name multiplesclerosis has evolved Types of MS There are almost as many different forms of MS as there are people with ... Managing Your MultipleSclerosis is not a book about what MS is, its causes and diagnosis It is a practical guide to its management and there is more information to be found in Multiple Sclerosis...